Exact Sciences
EXAS
#1154
Rank
C$26.77 B
Marketcap
C$141.08
Share price
-0.07%
Change (1 day)
60.70%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.43. In 2024 the company made an earnings per share (EPS) of C-$7.78.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-1.86%
2024C-$7.78
2022C-$4.942.31%
2021C-$4.83-38.54%
2020C-$7.86692.96%
2019C-$0.99-50.69%
2018C-$2.0144%
2017C-$1.40-39.39%
2016C-$2.30-2.94%
2015C-$2.3737.1%
2014C-$1.7379.71%
2013C-$0.96-21.59%
2012C-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
C-$6.04-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.47-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
C$0.54-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$71.05 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.17-169.66%๐Ÿ‡ซ๐Ÿ‡ท France